Time-dependent metabolomic profiling of Ketamine drug action reveals hippocampal pathway alterations and biomarker candidates

por Weckmann, K, Labermaier, C, Asara, J M, Müller, M B, Turck, C W
Publicado 2014

Metabolite profiling of antidepressant drug action reveals novel drug targets beyond monoamine elevation

por Webhofer, C, Gormanns, P, Tolstikov, V, Zieglgänsberger, W, Sillaber, I, Holsboer, F, Turck, C W
Publicado 2011

Plasma fibrinogen: now also an antidepressant response marker?

por Martins-de-Souza, D, Maccarrone, G, Ising, M, Kloiber, S, Lucae, S, Holsboer, F, Turck, C W
Publicado 2014

Identifying individual differences of fluoxetine response in juvenile rhesus monkeys by metabolite profiling

por He, Y, Hogrefe, C E, Grapov, D, Palazoglu, M, Fiehn, O, Turck, C W, Golub, M S
Publicado 2014

Delineation of molecular pathway activities of the chronic antidepressant treatment response suggests important roles for glutamatergic and ubiquitin–proteasome systems

por Park, D I, Dournes, C, Sillaber, I, Ising, M, Asara, J M, Webhofer, C, Filiou, M D, Müller, M B, Turck, C W
Publicado 2017

Modulation of cognition and neuronal plasticity in gain- and loss-of-function mouse models of the schizophrenia risk gene Tcf4

por Badowska, D. M., Brzózka, M. M., Kannaiyan, N., Thomas, C., Dibaj, P., Chowdhury, A., Steffens, H., Turck, C. W., Falkai, P., Schmitt, A., Papiol, S., Scheuss, V., Willig, K. I., Martins-de-Souza, D., Rhee, J. S., Malzahn, D., Rossner, M. J.
Publicado 2020